Do phenothiazines contribute to tumour regressions in lymphokine-activated killer cell/interleukin-2 treatments of renal cell cancer?

Ítems similars

• Lysis of primary hepatic tumours by lymphokine activated killer cells.
  per: Hsieh, K H, et al.
  Publicat: (1987)
• Role of prolactin in the in vitro development of interleukin-2-driven anti-tumoural lymphokine-activated killer cells.
  per: Matera, L, et al.
  Publicat: (1996)
• Efficacy of chemoimmunotherapy with cyclophosphamide, interleukin-2 and lymphokine activated killer cells in an intraperitoneal murine tumour model.
  per: Eggermont, A. M., et al.
  Publicat: (1988)
• Renal allograft rejection: possible involvement of lymphokine-activated killer cells.
  per: Kirby, J A, et al.
  Publicat: (1989)
• Interleukin 5 enhances interleukin 2-mediated lymphokine-activated killer activity
  Publicat: (1989)